| 1 |
34288357 | Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial. | 2021 Sep |
2 |
| 2 |
34784398 | Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study. | 2021 |
1 |
| 3 |
32941476 | A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV. | 2020 |
2 |
| 4 |
27615375 | Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir. | 2017 Feb |
5 |
| 5 |
27655859 | Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients. | 2017 Jan |
4 |
| 6 |
26380343 | Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir. | 2015 Apr |
2 |
| 7 |
25320633 | Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial. | 2014 |
1 |
| 8 |
25462535 | Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals. | 2014 |
1 |
| 9 |
23392458 | Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification. | 2013 Jun 1 |
3 |
| 10 |
22290239 | Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. | 2012 |
3 |
| 11 |
22820612 | Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. | 2012 Aug 24 |
1 |
| 12 |
22948290 | A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. | 2012 |
1 |
| 13 |
22992577 | The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients. | 2012 Sep 24 |
1 |
| 14 |
23018435 | Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery. | 2012 Nov 28 |
3 |